World’s best-selling drug costs five times more in U.S. than Europe
02:26
Critics accuse the maker of Humira of exploiting U.S. patent laws to keep competitors’ less expensive versions off the market. The company, AbbVie, says it’s balancing the need to keep the drug affordable to patients with the need to fund new drug development.Feb. 19, 2019
UP NEXT
FDA Commissioner grilled on when baby formula will return to shelves
05:01
Federal Reserve faces a tough challenge on cooling inflation
01:46
New exhibition at the National Gallery of Art gives viewers global journey through Black history
01:39
Memorial Day vacationers hit with high travel and lodging costs